Monitoring effectiveness of nirsevimab immunization against RSV hospitalization using surveillance data: a test-negative case-control study, Spain, October 2024-March 2025.
Saved in:
| Title: | Monitoring effectiveness of nirsevimab immunization against RSV hospitalization using surveillance data: a test-negative case-control study, Spain, October 2024-March 2025. |
|---|---|
| Authors: | Campos Mena S; National School of Health, Institute of Health Carlos III, Madrid, Spain.; National Distance Education University (UNED), Madrid, Spain., Pérez-Gimeno G; CB06/02/0085, Biomedical Research Networking Centre on Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Department of Communicable Diseases, Centre of Epidemiology, Carlos III Health Institute (CNE-ISCIII), Madrid, Spain., Lorusso N; Health and Consumption Department, General Directorate of Public Health and Pharmaceutical Management of Andalusia, Spain., Álvarez Río V; Epidemiology Service, General Directorate of Public Health, Castilla y León, Spain., Basile L; Department of Health, Public Health Agency of Catalonia (ASPCAT), Catalunya, Spain., Batalla Rebollo N; Subdirectorate of Epidemiology, General Directorate of Public Health, Extremadura, Spain., García-Comas L; Communicable Diseases Area, General Subdirectorate of Public Health, General Directorate of Public Health, Madrid, Spain., Andreu Ivorra B; Department of Epidemiology, Regional Health Council, IMIB, Murcia, Spain., Pérez-Panadés J; General Subdirectorate of Epidemiology, Health Surveillance and Environmental Health, General Directorate of Public Health, Comunitat Valenciana, Spain., Ramos Marín V; Epidemiological Surveillance Service, General Directorate of Public Health, Ceuta, Spain., Castrillejo D; Epidemiological Surveillance Service, General Directorate of Public Health, Melilla, Spain., Fernández Ibáñez A; Epidemiological Surveillance Section, General Directorate of Public Health and Mental Health, Asturias, Spain., Rafael de la Cruz López MÁ; Epidemiology Service, General Directorate of Public Health, Castilla-La Mancha, Spain., Núñez O; CB06/02/0085, Biomedical Research Networking Centre on Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Department of Communicable Diseases, Centre of Epidemiology, Carlos III Health Institute (CNE-ISCIII), Madrid, Spain., Monge S; Department of Communicable Diseases, Centre of Epidemiology, Carlos III Health Institute (CNE-ISCIII), Madrid, Spain.; CB21/13/00091, Biomedical Research Networking Centre on Infectious Diseases (CIBERINFEC), Madrid, Spain. |
| Corporate Authors: | SiVIRA group |
| Source: | Epidemiology and infection [Epidemiol Infect] 2025 Dec 09; Vol. 154, pp. e5. Date of Electronic Publication: 2025 Dec 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cambridge University Press Country of Publication: England NLM ID: 8703737 Publication Model: Electronic Cited Medium: Internet ISSN: 1469-4409 (Electronic) Linking ISSN: 09502688 NLM ISO Abbreviation: Epidemiol Infect Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
